| Application no. and date | 14741142.5 (espacenet) (Federated) (European Patent Register), 20140115 | | Patent/reg. no. and date | DK/EP 2945647, 20200909 | | Publication date | 20151125 | | Priority no. and date | US 201361752799 P, 20130115 | | EP pub. no. and date |
EP 2945647 20151125 | | Effective date | | | Applicant/owner | Memorial Sloan Kettering Cancer Center, 1275 York Avenue
New York, NY 10021, US | | Applicant ref. no. | BBS150989EPDK | | Inventor | SCHEINBERG, David A., 415 East 68th
19th Floor
New York, NY 10025, US,
DAO, Tao, 245 E 87th
Apt 14F
New York, NY 10128, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/38 (2006.01) | | Title | IMMUNOGENE WT-1-PEPTIDER OG ANVENDELSESMETODER DERAF | | Int. application no. | US2014011711 | | Int. publication no. | WO2014113490 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
